134 related articles for article (PubMed ID: 7555421)
1. Growth suppression of human colorectal carcinoma in nude mice by monoclonal antibody C27-abrin A chain conjugate.
Tsai LC; Chen YL; Lee C; Chen HM; Chang ZN; Hung MW; Chao PL; Lin JY
Dis Colon Rectum; 1995 Oct; 38(10):1067-74. PubMed ID: 7555421
[TBL] [Abstract][Full Text] [Related]
2. Selective cytotoxic effects of immunotoxin--monoclonal anti-AFP-abrin-A chain conjugate on several human hepatoma cell lines.
Chow LP; Chang KH; Lin JY
Biochem Int; 1990 Oct; 22(1):95-102. PubMed ID: 1704234
[TBL] [Abstract][Full Text] [Related]
3. Comparison of two anti-Thy 1.1-abrin A-chain immunotoxins prepared with different cross-linking agents: antitumor effects, in vivo fate, and tumor cell mutants.
Thorpe PE; Blakey DC; Brown AN; Knowles PP; Knyba RE; Wallace PM; Watson GJ; Wawrzynczak EJ
J Natl Cancer Inst; 1987 Nov; 79(5):1101-12. PubMed ID: 2890786
[TBL] [Abstract][Full Text] [Related]
4. Molecular and biological properties of an abrin A chain immunotoxin designed for therapy of human small cell lung cancer.
Wawrzynczak EJ; Zangemeister-Wittke U; Waibel R; Henry RV; Parnell GD; Cumber AJ; Jones M; Stahel RA
Br J Cancer; 1992 Aug; 66(2):361-6. PubMed ID: 1323991
[TBL] [Abstract][Full Text] [Related]
5. Suppression of the growth of human colorectal carcinoma cells (LS174T) by radiolabeled monoclonal antibody (131I-MAbC27) in tissue culture and nude mice.
Tsai LC; Lin JK; Han SH; Chen HM
Dis Colon Rectum; 1988 Oct; 31(10):781-5. PubMed ID: 3262492
[TBL] [Abstract][Full Text] [Related]
6. Monensin in lipid emulsion for the potentiation of ricin A chain immunotoxins.
Griffin T; Raso V
Cancer Res; 1991 Aug; 51(16):4316-22. PubMed ID: 1868454
[TBL] [Abstract][Full Text] [Related]
7. Abrin immunotoxin: targeted cytotoxicity and intracellular trafficking pathway.
Gadadhar S; Karande AA
PLoS One; 2013; 8(3):e58304. PubMed ID: 23472175
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancer.
Calvete JA; Newell DR; Wright AF; Rose MS
Cancer Res; 1994 Sep; 54(17):4684-90. PubMed ID: 8062265
[TBL] [Abstract][Full Text] [Related]
9. Selective antitumor effect on L10 hepatocarcinoma cells of a potent immunoconjugate composed of the A chain of abrin and a monoclonal antibody to a hepatoma-associated antigen.
Hwang KM; Foon KA; Cheung PH; Pearson JW; Oldham RK
Cancer Res; 1984 Oct; 44(10):4578-86. PubMed ID: 6467213
[TBL] [Abstract][Full Text] [Related]
10. Synergistic interaction between anti-p185HER-2 ricin A chain immunotoxins and radionuclide conjugates for inhibiting growth of ovarian and breast cancer cells that overexpress HER-2.
Xu F; Leadon SA; Yu Y; Boyer CM; O'Briant K; Ward K; McWatters A; Zhao X; Bae DS; DeSombre K; Zalutsky MR; Bast RC
Clin Cancer Res; 2000 Aug; 6(8):3334-41. PubMed ID: 10955821
[TBL] [Abstract][Full Text] [Related]
11. [Experimental studies on therapeutic effect of rat monoclonal antibody-bleomycin A6 conjugate against human colorectal cancer].
Deng YC; Zhen YS; Zheng S; Jiang M
Yao Xue Xue Bao; 1993; 28(6):410-5. PubMed ID: 7504390
[TBL] [Abstract][Full Text] [Related]
12. Immunotoxins to a human melanoma-associated antigen: comparison of gelonin with ricin and other A chain conjugates.
Sivam G; Pearson JW; Bohn W; Oldham RK; Sadoff JC; Morgan AC
Cancer Res; 1987 Jun; 47(12):3169-73. PubMed ID: 3495329
[TBL] [Abstract][Full Text] [Related]
13. Chimeric protein: abrin B chain-trypsin inhibitor conjugate as a new antitumor agent.
Lin JY; Hsieh YS; Chu SC
Biochem Int; 1989 Aug; 19(2):313-23. PubMed ID: 2818599
[TBL] [Abstract][Full Text] [Related]
14. Suppression of an epidermal growth factor receptor-hyperproducing tumor by an immunotoxin conjugate of gelonin and a monoclonal anti-epidermal growth factor receptor antibody.
Hirota N; Ueda M; Ozawa S; Abe O; Shimizu N
Cancer Res; 1989 Dec; 49(24 Pt 1):7106-9. PubMed ID: 2555059
[TBL] [Abstract][Full Text] [Related]
15. Anti-tumor activity of T-2 toxin-conjugated A7 monoclonal antibody (T-2-A7 MoAb) against human colon carcinoma.
Kojima S; Nakamura N; Ueno Y; Yamaguchi T; Takahashi T
Nat Toxins; 1993; 1(4):209-15. PubMed ID: 8167936
[TBL] [Abstract][Full Text] [Related]
16. Establishment of new SCID and nude mouse models of human B leukemia/lymphoma and effective therapy of the tumors with immunotoxin and monoclonal antibody: marked difference between the SCID and nude mouse models in the antitumor efficacy of monoclonal antibody.
Kawata A; Yoshida M; Okazaki M; Yokota S; Barcos M; Seon BK
Cancer Res; 1994 May; 54(10):2688-94. PubMed ID: 8168098
[TBL] [Abstract][Full Text] [Related]
17. Potentiation of antitumor immunotoxins by liposomal monensin.
Griffin T; Rybak ME; Recht L; Singh M; Salimi A; Raso V
J Natl Cancer Inst; 1993 Feb; 85(4):292-8. PubMed ID: 8426373
[TBL] [Abstract][Full Text] [Related]
18. Antitumour activity of a sterically blocked ricin immunotoxin on a human colorectal adenocarcinoma grafted subcutaneously in nude mice.
Brusa P; Dosio F; Pietribiasi F; Delprino L; Feraiorni P; Mariani M; Bussolati G; Cattel L
Cancer Immunol Immunother; 1992; 35(6):373-80. PubMed ID: 1394342
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo antitumor activity of immunoconjugates prepared by linking 5-fluorouridine to antiadenocarcinoma monoclonal antibody.
Brusa P; Dosio F; Coppo S; Pacchioni D; Arpicco S; Crosasso P; Cattel L
Farmaco; 1997 Feb; 52(2):71-81. PubMed ID: 9181686
[TBL] [Abstract][Full Text] [Related]
20. Blocked and not blocked whole-ricin-antibody immunotoxins: intraperitoneal therapy of human tumour xenografted in nude mice.
Brusa P; Pietribiasi F; Bussolati G; Dosio F; Arione R; Comoglio PM; Prat M; Cattel L
Cancer Immunol Immunother; 1989; 29(3):185-92. PubMed ID: 2659170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
